Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STAAR SURGICAL COSTAA · Entity 4851 | Director | June 18, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STAAR SURGICAL CO
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 3,091 |
Reported balance
After 2026-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 3,091 · Balance 3,091 F1: Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $29.12 · Expires 2036-06-17 | Direct | 5,572 |
Reported balance
After 2026-06-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-18 · Grant · Acquired 5,572 · Balance 5,572 F1: Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 22, 2026 20:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 5,572 | $0.00 Strike: $29.12 | $0.00 |
DisclosureSEC source: 0002003105-26-000005 · ownership.xml · derivative · entry 2 Zhou Lilian Yansheng · CIK 0002003105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,572 Underlying: Common Stock · 5,572 shares Expires 2036-06-17 F1 · security: Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 3,091 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002003105-26-000005 · ownership.xml · derivative · entry 1 Zhou Lilian Yansheng · CIK 0002003105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,091 Underlying: Common Stock · 3,091 shares Expires not disclosed F1 · security: Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. F1 · derivative.exercise_date: Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. F1 · derivative.expiration_date: Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 20:10 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 3,530 | $28.29 | $99,865.11 |
DisclosureSEC source: 0001193125-26-271092 · ownership.xml · nonDerivative · entry 1 Zhou Lilian Yansheng · CIK 0002003105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,101 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.215 to $28.35, inclusive. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 22:29 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 4,363 | $0.00 Strike: $16.72 | $0.00 |
DisclosureSEC source: 0000950170-25-090532 · ownership.xml · derivative · entry 1 Zhou Lilian Yansheng · CIK 0002003105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,363 Underlying: Common Stock · 4,363 shares Expires 2035-06-24 F1 · derivative.exercise_date: Award of stock options granted to the Reporting Person on June 25, 2025. These stock options will vest as to 1/4 of the shares subject to the award on a quarterly basis on each of September 25, 2025, December 25, 2025, March 25, 2026, and June 25, 2026. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 21:21 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 19,415 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0000950170-25-088593 · ownership.xml · derivative · entry 1 Zhou Lilian Yansheng · CIK 0002003105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,415 Underlying: Common Stock · 19,415 shares Expires 2035-06-17 F1 · derivative.exercise_date: These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 4,010 | $0.00 Strike: $40.11 | $0.00 |
DisclosureSEC source: 0000950170-24-076866 · ownership.xml · derivative · entry 2 Zhou Lilian Yansheng · CIK 0002003105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,010 Underlying: Common Stock · 4,010 shares Expires 2034-06-19 F1 · security: Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term. These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 2,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076866 · ownership.xml · nonDerivative · entry 1 Zhou Lilian Yansheng · CIK 0002003105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,571 F1 · security: Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term. These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders. Read SEC document |
| December 06, 2023 Filed Dec 6, 2023 21:11 UTC | STAAR SURGICAL CO STAA · Entity 4851 | PurchaseCommon Stock | 850 | $30.74 | $26,129.00 |
DisclosureSEC source: 0001209191-23-057597 · doc4.xml · nonDerivative · entry 1 Zhou Lilian Yansheng · CIK 0002003105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,327 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.71 to $30.75, inclusive. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 22:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock · Derivative | 2,686 | $0.00 Strike: $32.29 | $0.00 |
DisclosureSEC source: 0001209191-23-057467 · doc4.xml · derivative · entry 2 Zhou Lilian Yansheng · CIK 0002003105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,686 Underlying: Common Stock · 2,686 shares Expires 2034-06-15 F2 · derivative.exercise_date: The options shall vest in full on the earlier of June 16, 2024, or the Corporation's 2024 Annual Shareholders Meeting. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 22:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 1,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057467 · doc4.xml · nonDerivative · entry 1 Zhou Lilian Yansheng · CIK 0002003105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,477 F1 · shares: Includes restricted shares of common stock awarded on her appointment to the Board, which vest in full on the earlier of June 16, 2024, or the Corporation's 2024 Annual Shareholders Meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.